University of Maryland Baltimore Washington Medical Center (BWMC)

EDDS Highlights & EHR Quarterly Results: Q3-2021

December 9, 2021

UM Baltimore Washington Medical Center Center for Substance Abuse Research

University of Maryland Baltimore Washington Medical Center (BWMC)

New Quarterly Drug Test Results from the Hospital's Electronic Health Records Released, July-September 2021

BWMC submitted results for 58 patients tested by the hospital between July 1, 2021-September 30, 2021, data series now extends from May 2017September 2021.

Highlights

Compared with the same period one year ago, the number of tested patients declined from 88 to 58 (Table 1). The percentage that tested positive for cocaine (35%) has reached a series high (Table 1). Cocaine (35%), marijuana (35%), and benzodiazepines (26%) were the most frequently detected drugs (Figure 1). Cocaine positives were at the top of the 5-year range, while positives for opiates, methadone, and barbiturates were near the bottom (Figure 2).

The information and opinions expressed herein are the views of the authors (CESAR). For additional data: .

Emergency Department Drug Surveillance (EDDS)

1 of 4

Center for Substance Abuse Research (CESAR)

Table 1: Drugs Detected in Specimens from University of Maryland Baltimore Washington Medical Center (BWMC) Emergency Department (ED) Drug Overdose Patients, By Quarter

(N=1,311 specimens collected from May 2017 through September 2021)

Quarter (N of specimens tested) May-June 2017b (41) July-September 2017 (95) October-December 2017 (84) January-March 2018 (98) April-June 2018 (106) July-September 2018 (78) October-December 2018 (71) January-March 2019 (60) April-June 2019 (80) July-September 2019 (79) October-December 2019 (51) January-March 2020 (60) April-June 2020 (55) July-September 2020 (88) October-December 2020 (71) January-March 2021 (60) April-June 2021 (76) July-September 2021 (58)

Marijuana % 27 32 29 26 28 32 27 25 25 27 24 35 18 L 26 32 32 42 H 35

Opiates % 46 H 31 31 27 26 30 31 22 21 28 26 18 22 21 32 17 L 24 21

PCP % 2 4 2 1 6 4 7 5 6 1 L 2 3 4 5 4 15 H 3 7

Cocaine % 32 27 26 26 22 32 20 22 30 27

29 23 22 27 18 L 33 32 35 H

Benzodiazepines % 29 43 H 30 22 28 27 39 28 35 32 33 37 16 L 31 39 32 29 26

Amphetamines % 7 6 6 5 8 10 4 5 6 5 4 10 7 9 11 H 2 L 8 7

Methadone % 15 12 13 7 10 10 9 5 L 19 10 14 13 16 13 16 15 22 H 9

Barbiturates % 5 3 5 H 2 2 0 0 0 1 0 2 2 2 1 4 0 0 0 L

Oxycodonea % 12 11 10 16 15 16 9 14 5 L 16 H 12

Notes: H: Highest %. L: Lowest %. If there are multiple highs or lows, the most recent quarter is selected as the high/low. aOxycodone was added to the BWMC standard panel in late January 2019. bToxicology results available beginning May 2017. Only partial quarter data available for this calendar quarter.

Compared with the same period one year ago, the number of tested patients declined from 88 to 58. The percentage that tested positive for cocaine (35%) has reached a series high.

Emergency Department Drug Surveillance (EDDS)

2 of 4

Center for Substance Abuse Research (CESAR)

Cocaine (35%), marijuana (35%), and benzodiazepines (26%) were the most frequently detected drugs.

Emergency Department Drug Surveillance (EDDS)

3 of 4

Center for Substance Abuse Research (CESAR)

Cocaine positives were at the top of the 5-year range, while positives for opiates, methadone, and barbiturates were near the bottom.

Emergency Department Drug Surveillance (EDDS)

4 of 4

Center for Substance Abuse Research (CESAR)

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download